CCRN Latest Report

Performance of the Quarterly Report

Cross Country (CCRN) had a total operating revenue of RMB309940000 as of December 31, 2024, a year-on-year decrease of 25.14% from RMB414035000 as of December 31, 2023. This significant decline may negatively impact the company's profitability and market confidence.

Key Data in the Quarterly Report

1. Sales costs in 2024 were RMB247948000, down from RMB323546000 in 2023, but the decrease in revenue was greater, leading to a decline in overall gross margin.

2. Intensified market competition, Cross Country faced a more challenging market environment, affecting sales.

3. Sliding product demand may lead to a decrease in sales revenue.

4. Macroeconomic factors such as economic slowdown or insufficient consumer confidence have a negative impact on the company's business development.

5. There may be special expenses or non-current losses in 2024 that affect the performance of revenue.

Peer Comparison

1. Industry-wide analysis: The overall healthcare services industry has faced challenges in revenue growth slowdown in the past year, mainly affected by the recovery of the market after the pandemic and rising costs, and many peers also reported a decrease in revenue. The overall revenue of the healthcare services industry in the first three quarters of 2024 decreased by 4.8% year-on-year, and the decrease in net profit attributable to parent was more significant, reaching 30.8% [source].

2. Peer evaluation analysis: Compared with other companies in the same industry, Cross Country's revenue decline is significant, possibly due to the loss of market share or insufficient product competitiveness. Other companies maintained stable or slightly increased revenue in the same period, showing Cross Country's relative disadvantage in the market [source].

Summary

The decline in Cross Country (CCRN)'s revenue is mainly due to intensified market competition, declining product demand, and adverse macroeconomic factors. Although sales costs have decreased, the greater decrease in revenue has led to a decline in overall gross margin, indicating that the company faces many challenges in the market.

Opportunities

1. Strengthen R&D investment to develop new products to enhance market competitiveness.

2. Improve profitability through optimized cost control.

3. Find new markets or customer groups to achieve diversified revenue growth.

4. Utilize the growth opportunities of some enterprises in the industry and carry out strategic cooperation or acquisition.

Risks

1. Continuing to face intense market competition may lead to further decline in market share.

2. Macroeconomic uncertainties may put pressure on future revenue.

3. Increased R&D expenses may negatively impact short-term net profit.

4. If market demand remains sluggish, it may lead to a longer revenue decline.